Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

INTERIM MANAGEMENT STATEMENT

14 Nov 2024 09:43

RNS Number : 2756M
Mandarin Oriental International Ltd
14 November 2024
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

 

14 November 2024 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2024.

Laurent Kleitman, Group Chief Executive, said:

"One year after my joining Mandarin Oriental, I am pleased to see increasing positive momentum across our business. Our vision to elevate the brand and strategy to accelerate growth are in place and have been communicated to all our 15,000 colleagues globally. We are building new capabilities, new governance and a new culture to drive Exceptional growth and are focused now on executing and delivering results. We will measure ourselves in the long term in terms of accelerated growth from our development pipeline, differentiated innovation and service, and improved financial performance. The strength of our Brand will remain the bedrock of future success of our business."

In the third quarter, Revenue per Available Room ('RevPAR') increased year on year across all regions. In Asia, both rates and occupancy were fuelled by strong intra-regional demand, with Tokyo and South East Asia performing well. In Europe, the Middle East and Africa, almost all hotels were able to deliver solid improvements in RevPAR supported by both rate and occupancy. In America, with rates flat, our hotels delivered RevPAR growth through increases in occupancy.

With higher RevPARs in the period, the Management Business generated stronger hotel management fee income and improved profitability, excluding Residences branding fees. Owned Hotels, particularly Singapore, Munich, and Madrid, recorded solid improvements in earnings from last year, partially offset by the absence of earnings from Paris as a result of the disposal of that hotel. Overall, the Group's underlying profit in the quarter was slightly below the prior year due to lower branding fees.

On the development front, in September, the Group opened its second property in Beijing - Mandarin Oriental Qianmen, Beijing, a one-of-a-kind hutong experience already delivering some of the highest rates in China. This year, the Group has made excellent progress in accelerating the growth of its portfolio with four new hotel and residences management contracts: a luxurious hideaway with private branded residences on Bali's southern coast, a unique hotel meticulously restoring the 19th-century charm in the heart of Rome, a resort with branded residences on Mexico's Riviera Maya on the Yucatan Peninsula marking the Group's debut in the market, and a standalone residences project in Abu Dhabi.

Consolidated net debt significantly decreased from US$225 million as at 31 December 2023 to US$26 million as at 30 September 2024, mainly due to the receipt of sale proceeds from Paris hotel and retail properties, partially offset by investment in One Causeway Bay - the Group's mixed-use commercial redevelopment in Hong Kong. The Group's liquidity position remains robust, with over US$700 million in available committed debt facilities and cash reserves. Gearing was 1% of adjusted shareholders' funds, reduced from 5% at the end of last year.

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the world's most luxurious hotels, resorts and residences. Having grown from its Asian roots into a global brand, the Group now operates 41 hotels, 12 residences and 26 exclusive homes in 26 countries and territories, with each property reflecting the Group's oriental heritage, local culture and unique design. Mandarin Oriental has a strong pipeline of hotels and residences under development.

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The activities of the Group's hotels are managed from Hong Kong. Mandarin Oriental is a member of the Jardine Matheson Group.

 

 

- end -

 

 

For further information, please contact:

 

Max Fleming (Director of Corporate Finance) (852) 2895 9171

 

Chris Orlikowski (Director of Global Communications) (44) 791 7280 210

William Brocklehurst (Brunswick Group Limited) (852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKZLBFZFLZFBF
Date   Source Headline
2nd Mar 202310:27 amRNSAudit Committee Chairman and Membership Changes
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
31st Jan 202310:49 amRNSTotal Voting Rights
10th Nov 20229:42 amRNSInterim Management Statement
26th Sep 202210:21 amRNSBlock listing Interim Review
28th Jul 202210:28 amRNSHalf Year Results
18th Jul 20225:19 pmRNSMO announces Sale of MO, Washington D.C.
19th May 202210:27 amRNSInterim Management Statement
5th May 202212:40 pmRNSResult of AGM
7th Apr 202210:35 amRNSAnnual Financial Report
31st Mar 202211:34 amRNSTotal Voting Rights
25th Mar 20229:28 amRNSBlock listing Interim Review
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
31st Jan 20227:18 amRNSTotal Voting Rights
31st Dec 20217:01 amRNSTotal Voting Rights
30th Nov 20219:43 amRNSTotal Voting Rights
19th Nov 20219:28 amRNSDirectorate Change
11th Nov 20219:41 amRNSInterim Management Statement
22nd Oct 202110:18 amRNSDirectorate Change
27th Sep 202110:23 amRNSBlock listing Interim Review
30th Jul 202110:20 amRNSTotal Voting Rights
29th Jul 202110:38 amRNSDirectorate Change
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
30th Jun 202110:21 amRNSTotal Voting Rights
1st Jun 20217:02 amRNSTotal Voting Rights
20th May 20217:00 amRNSDirectorate Change
5th May 20211:25 pmRNSResult of AGM
5th May 202110:24 amRNSInterim Management Statement
30th Apr 202110:30 amRNSTotal Voting Rights
16th Apr 202110:26 amRNSHolding(s) in Company
8th Apr 202110:31 amRNSAnnual Financial Report
25th Mar 20219:27 amRNSBlock listing Interim Review
24th Mar 20219:47 amRNSDirector Declaration
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
3rd Dec 202012:30 pmRNSDirectorate Change
5th Nov 20209:27 amRNSInterim Management Statement
27th Oct 20209:27 amRNSDirectorate Change
27th Oct 20209:21 amRNSDirectorate Change
25th Sep 202010:50 amRNSBlock listing Interim Review
25th Sep 202010:47 amRNSDirector/PDMR Shareholding
30th Jul 202011:01 amRNSHalf-year Report
15th Jun 202010:22 amRNSDirector Declaration
29th May 202010:20 amRNSTotal Voting Rights
6th May 20201:13 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20201:07 pmRNSResult of AGM
9th Apr 202010:21 amRNSInterim Management Statement
9th Apr 20207:38 amRNSAdditional Listing
7th Apr 202010:30 amRNSAnnual Financial Report
30th Mar 202011:07 amRNSDirector Declaration
25th Mar 20209:27 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.